David A. Siegel Charles River Laboratories International, Inc. Transaction History

Two Sigma Advisers, LP

$42.5 Billion
Q1 2024

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 24,200 shares of CRL stock, worth $5 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

24,200

Previous 25,700 5.84%

Holding current value

$5 Million

Previous $6.08 Million 7.92%

% of portfolio

0.02%

Previous 0.01%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$203.52 - $273.43 $305,280 - $410,145	-1,500 Reduced 5.84%	24,200 $6.56 Million
Q4 2023 Feb 14, 2024	SELL	$164.52 - $238.84 $16,452 - $23,884	-100 Reduced 0.39%	25,700 $6.08 Million
Q3 2023 Nov 14, 2023	SELL	$194.44 - $217.61 $544,432 - $609,308	-2,800 Reduced 9.79%	25,800 $5.06 Million
Q2 2023 Aug 14, 2023	SELL	$183.71 - $210.25 $2.06 Million - $2.35 Million	-11,200 Reduced 28.14%	28,600 $6.01 Million
Q1 2023 May 15, 2023	SELL	$191.89 - $259.92 $10.6 Million - $14.4 Million	-55,400 Reduced 58.19%	39,800 $8.03 Million

Q4 2022 Feb 14, 2023	SELL	$197.11 - $250.07 $29.8 Million - $37.8 Million	-151,100 Reduced 61.35%	95,200 $20.7 Million
Q3 2022 Nov 14, 2022	BUY	$182.44 - $250.54 $492,588 - $676,458	2,700 Added 1.11%	246,300 $48.5 Million
Q3 2022 Nov 14, 2022	BUY	$182.44 - $250.54 $492,588 - $676,458	2,700 Added 1.11%	246,300 $48.5 Million
Q2 2022 Aug 15, 2022	BUY	$204.13 - $302.4 $13.1 Million - $19.4 Million	64,300 Added 35.86%	243,600 $52.1 Million
Q1 2022 May 16, 2022	BUY	$255.51 - $362.11 $38.3 Million - $54.2 Million	149,800 Added 507.8%	179,300 $50.9 Million
Q4 2021 Feb 14, 2022	BUY	$351.38 - $448.68 $2.32 Million - $2.96 Million	6,600 Added 28.82%	29,500 $11.1 Million
Q3 2021 Nov 15, 2021	BUY	$372.64 - $458.3 $8.53 Million - $10.5 Million	22,900 New	22,900 $9.45 Million
Q1 2021 May 17, 2021	SELL	$249.67 - $299.48 $2.1 Million - $2.52 Million	-8,400 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$222.0 - $252.62 $9.57 Million - $10.9 Million	-43,100 Reduced 83.69%	8,400 $2.1 Million
Q3 2020 Nov 16, 2020	SELL	$175.56 - $226.45 $4.16 Million - $5.37 Million	-23,700 Reduced 31.52%	51,500 $11.7 Million
Q2 2020 Aug 14, 2020	BUY	$118.84 - $189.72 $3.72 Million - $5.94 Million	31,300 Added 71.3%	75,200 $13.1 Million
Q1 2020 May 15, 2020	BUY	$98.9 - $178.34 $4.15 Million - $7.49 Million	42,000 Added 2210.53%	43,900 $5.54 Million
Q4 2019 Feb 14, 2020	SELL	$126.05 - $152.76 $932,770 - $1.13 Million	-7,400 Reduced 79.57%	1,900 $290,000
Q3 2019 Nov 14, 2019	SELL	$125.07 - $143.67 $775,434 - $890,753	-6,200 Reduced 40.0%	9,300 $1.23 Million
Q2 2019 Aug 14, 2019	SELL	$123.4 - $148.55 $2.06 Million - $2.48 Million	-16,700 Reduced 51.86%	15,500 $2.2 Million
Q1 2019 May 15, 2019	SELL	$104.82 - $146.73 $681,330 - $953,744	-6,500 Reduced 16.8%	32,200 $4.68 Million
Q4 2018 Feb 14, 2019	SELL	$105.09 - $137.23 $1.62 Million - $2.12 Million	-15,454 Reduced 28.54%	38,700 $4.38 Million
Q3 2018 Nov 14, 2018	SELL	$112.11 - $134.54 $2.62 Million - $3.15 Million	-23,400 Reduced 30.17%	54,154 $7.29 Million
Q2 2018 Aug 14, 2018	SELL	$102.37 - $117.25 $531,914 - $609,231	-5,196 Reduced 6.28%	77,554 $8.71 Million
Q1 2018 May 15, 2018	BUY	$98.19 - $115.2 $471,312 - $552,960	4,800 Added 6.16%	82,750 $8.83 Million
Q4 2017 Feb 14, 2018	SELL	$100.43 - $118.09 $4.82 Million - $5.67 Million	-48,000 Reduced 38.11%	77,950 $8.53 Million
Q3 2017 Nov 14, 2017	BUY	$96.72 - $109.26 $12.2 Million - $13.8 Million	125,950	125,950 $13.6 Million

Others Institutions Holding CRL

# of Institutions

727

Shares Held

51.3M

Call Options Held

183K

Put Options Held

346K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.5B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account